Bayer Statistics
Share Statistics
Bayer has 3.93B
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 3.93B |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.5% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,144 |
| FTD / Avg. Volume | 1.05% |
Short Selling Information
The latest short interest is 142.99K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 142.99K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -7.26 and the forward
PE ratio is null.
Bayer's PEG ratio is
0.56.
| PE Ratio | -7.26 |
| Forward PE | n/a |
| PS Ratio | 0.4 |
| Forward PS | n/a |
| PB Ratio | 0.58 |
| P/FCF Ratio | 4.03 |
| PEG Ratio | 0.56 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Bayer.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19,
with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.19 |
| Quick Ratio | 0.73 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 4.62 |
| Debt / FCF | 8.87 |
| Interest Coverage | 1.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $514,488.83 |
| Profits Per Employee | $-28,171.81 |
| Employee Count | 90,587 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.59 |
Taxes
| Income Tax | 212M |
| Effective Tax Rate | -9.08% |
Stock Price Statistics
The stock price has increased by -13.05% in the
last 52 weeks. The beta is 0.98, so Bayer's
price volatility has been higher than the market average.
| Beta | 0.98 |
| 52-Week Price Change | -13.05% |
| 50-Day Moving Average | 6.29 |
| 200-Day Moving Average | 6.39 |
| Relative Strength Index (RSI) | 65.75 |
| Average Volume (20 Days) | 681,061 |
Income Statement
In the last 12 months, Bayer had revenue of 46.61B
and earned -2.55B
in profits. Earnings per share was -0.65.
| Revenue | 46.61B |
| Gross Profit | 25.34B |
| Operating Income | 3.33B |
| Net Income | -2.55B |
| EBITDA | 8.81B |
| EBIT | 24M |
| Earnings Per Share (EPS) | -0.65 |
Full Income StatementBalance Sheet
The company has 6.19B in cash and 40.7B in
debt, giving a net cash position of -34.51B.
| Cash & Cash Equivalents | 6.19B |
| Total Debt | 40.7B |
| Net Cash | -34.51B |
| Retained Earnings | n/a |
| Total Assets | 110.85B |
| Working Capital | 5.49B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 7.37B
and capital expenditures -2.78B, giving a free cash flow of 4.59B.
| Operating Cash Flow | 7.37B |
| Capital Expenditures | -2.78B |
| Free Cash Flow | 4.59B |
| FCF Per Share | 4.67 |
Full Cash Flow StatementMargins
Gross margin is 54.36%, with operating and profit margins of 7.14% and -5.48%.
| Gross Margin | 54.36% |
| Operating Margin | 7.14% |
| Pretax Margin | -5.01% |
| Profit Margin | -5.48% |
| EBITDA Margin | 18.9% |
| EBIT Margin | 7.14% |
| FCF Margin | 9.85% |
